chlorambucil,acalabrutinib,obinutuzumab
nippon shinyaku,gsk,biogen,astrazeneca,roche,acerta pharma
['lymsm', 'obinutuzumab', 'chlorambucil', 'leusm', 'acalabrutinib']
elevate-tn: #acalabrutinib with #obinutuzumab os benefits better than chlorambucil obinu despite allowed cross over to acal on progression. #lymsm #leusm #asco22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.